16,475
Views
81
CrossRef citations to date
0
Altmetric
Studies in Humans

Effect of consumption of chicory inulin on bowel function in healthy subjects with constipation: a randomized, double-blind, placebo-controlled trial

, , , &
Pages 82-89 | Received 22 Jun 2016, Accepted 11 Jul 2016, Published online: 05 Aug 2016

References

  • Abrams SA, Griffin IJ, Hawthorne KM, Liang L, Gunn SK, Darlington G, Ellis KJ. 2005. A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr. 82:471–476.
  • Brighenti F, Casiraghi MC, Canzi E, Ferrari A. 1999. Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur J Clin Nutr. 53:726–733.
  • Candelli M, Nista EC, Zocco MA, Gasbarrini A. 2001. Idiopathic chronic constipation: pathophysiology, diagnosis and treatment. Hepatogastroenterology. 48:1050–1057.
  • Castiglia-Delavaud C, Verdier E, Besle JM, Vernet J, Boirie Y, Beaufrere B, De Baynast R, Vermorel M. 1998. Net energy value of non-starch polysaccharide isolates (sugarbeet fibre and commercial inulin) and their impact on nutrient digestive utilization in healthy human subjects. Br J Nutr. 80:343–352.
  • Cherbut C, Ferrier L, Roze C, Anini Y, Blottière H, Lecannu G, Galmiche JP. 1998. Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am J Physiol. 275:G1415–G1422.
  • Collado Yurrita L, San Mauro Martin I, Ciudad-Cabanas MJ, Calle-Purón ME, Hernández Cabria M. 2014. Effectiveness of inulin intake on indicators of chronic constipation; a meta-analysis of controlled randomized clinical trials. Nutr Hosp. 30:244–252.
  • Corazziari E. 1999. Need of the ideal drug for the treatment of chronic constipation. Ital J Gastroenterol Hepatol. 31:S232–S233.
  • Cummings JH, Macfarlane GT, Englyst HN. 2001. Prebiotic digestion and fermentation. Am J Clin Nutr. 73:415S–420S.
  • Deutsche Gesellschaft für Ernährung. 2015. Referenzwerte für die Nährstoffzufuhr. 2. Auflage, 1. Ausgabe.
  • Den Hond E, Geypens B, Ghoos Y. 2000. Effect of high performance chicory inulin on constipation. Nutrit Res. 20:731–736.
  • EFSA NDA Panel (EFSA Panel on Dietetic Products). 2010. Scientific opinion on dietary reference values for carbohydrates and dietary fibre. EFSA J. 8:1462.
  • EFSA NDA Panel (EFSA Panel on on Dietetic Products, Nutrition and Allergies). 2011. Guidance on the scientific requirements for health claims related to gut and immune function. EFSA J. 9:1984.
  • EFSA NDA Panel (EFSA Panel on Dietetic Products). 2015. Scientific opinion on the substantiation of a health claim related to “native chicory inulin” and maintenance of normal defecation by increasing stool frequency pursuant to Article 13.5 of Regulation (EC) No 1924/2006. EFSA J. 13:3951.
  • Ellegard L, Andersson H, Bosaeus I. 1997. Inulin and oligofructose do not influence the absorption of cholesterol, or the excretion of cholesterol, Ca, Mg, Zn, Fe, or bile acids but increases energy excretion in ileostomy subjects. Eur J Clin Nutr. 51:1–5.
  • Erhardt J. 2000. EBISpro die Software für Ernährungsberatung und Wissenschaft [Internet]. Available from: http://http://www.ebispro.de/.
  • Gibson GR, Beatty ER, Wang X, Cummings JH. 1995. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology. 108:975–982.
  • Grasten S, Liukkonen K, Chrevatidis A, El-Nezami H, Poutanen K, Mykkänen H. 2003. Effects of wheat pentosan and inulin on the metabolic activity of fecal microbiota and on bowel function in healthy humans. Nutrit Res. 23:1503–1514.
  • Grider JR, Piland BE. 2007. The peristaltic reflex induced by short-chain fatty acids is mediated by sequential release of 5-HT and neuronal CGRP but not BDNF. Am J Physiol Gastrointest Liver Physiol. 292:G429–G437.
  • Institute of Medicine. 2005. Dietary Reference values. Washington DC: The National Academic Press.
  • Isakov V, Pilipenko V, Shakhovskaya A, Tutelyan V. 2013. Efficacy of inulin enriched yogurt on bowel habits in patients with irritable bowel syndrome with constipation: a pilot study. FASEB J. 27:lb426.
  • Khoury V, Mouchet J. 2009. Mapi Research Trust Patient-Assessment of Constipation. Quality of Life questionnare. Information booklet. 2nd ed.
  • Kleessen B, Sykura B, Zunft HJ, Blaut M. 1997. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr. 65:1397–1402.
  • Lewis SJ, Heaton KW. 1997. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 32:920–924.
  • Marquis P, De La LC, Dubois D, McDermott A, Chassany O. 2005. Development and validation of the patient assessment of constipation quality of life questionnaire. Scand J Gastroenterol. 40:540–551.
  • Nationale Verzehrsstudie II. Ergebnisbericht Teil 2. 2008. Max Rubner Institut. Bundesforschungsanstalt für Ernährung und Lebensmittel, Karlsruhe. Available from: https://www.bmel.de/SharedDocs/Downloads/Ernaehrung/NVS_ErgebnisberichtTeil2.pdf?__blob=publicationFile.
  • Nishida C, Uauy R, Kumanyika S, Shetty P. 2004. The joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr. 7:245–250.
  • Parnell JA, Reimer RA. 2009. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr. 89:1751–1759.
  • Rantis PC, Vernava AM, Daniel GL, Longo WE. 1997. Chronic constipation-is the work-up worth the cost? Dis Colon Rectum. 40:280–286.
  • Roberfroid MB. 2005. Introducing inulin-type fructans. Br J Nutr. 93:S13–S25.
  • Roberfroid M, Slavin J. 2000. Nondigestible oligosaccharides. Crit Rev Food Sci Nutr. 40:461–480.
  • Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Wolvers D, Watzl B, Szajewska H, et al. 2010. Prebiotic effects: metabolic and health benefits. Br. J Nutr. 104:S1–S63.
  • Schaafsma G, Slavin JL. 2015. Significance of inulin fructans in the human diet. Compr Rev Food Sci Food Saf. 14:37–47.
  • US Department of Agriculture. 2010. Dietary Guidelines for Americans [Internet]. Available: http://www.dietaryguidelines.gov.
  • U.S. Department of Health and Human Services Food and Drug Administration. 2012. Guidance for Industry: Irritibable Bowel Syndrome - Clinical Evaluation of Drugs for Treatment. Available from: http://www.fda.gov/downloads/Drugs/.../Guidances/UCM205269.pdf.
  • Vogt L, Meyer D, Pullens G, Faas M, Smelt M, Venema K, Ramasamy U, et al. 2015. Immunological properties of inulin-type fructans. Crit Rev Food Sci Nutr. 55:414–436.
  • Wald A, Scarpignato C, Mueller-Lissner S, Kamm MA, Hinkel U, Helfrich I, Schuijt C, Mandel KG. 2008. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther. 28:917–930.